News

Medtronic to discontinue SmartPill capsule
A groundbreaking technology to pinpoint motility problems is being retired by its maker after 17 years on the market. Experts say there’s no easy...
A groundbreaking technology to pinpoint motility problems is being retired by its maker after 17 years on the market. Experts say there’s no easy...
Dr Harold Burstein highlights abstracts in early breast cancer from ASCO 2023, including the NATALEE trial of CDK4/6 inhibitor ribociclib and a...
Plus: Indiana loses its biggest Butt, and sugarless sweeteners lose the aftertaste.
Dr Harold Burstein highlights abstracts in metastatic breast cancer from ASCO 2023, including data on antibody-drug conjugates from the TROPiCS-02...
Observation was the dominant choice, based on economic modeling showing it to offer both the highest utility and the lowest cost.
Among first-time thyroid hormone prescriptions, those for DTE rose from 5.4% in 2010 to 10.2% in 2020.
Apolipoproteins “may be involved in the pathogenesis of DR-TB by accelerating the formation of foamy macrophages and reducing cellular uptake of...
MedPAC’s recommendation on Part B add-on pay for costly drugs met strong resistance, but reactions were mixed to a plan to reduce reimbursement...
Clinical practice update authors suggest that G-POEM should be covered by health insurance.
With COVID waning and masks doffed, I've found myself back to handshaking.